Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,205

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,841

Class I recallsReasonable probability of serious health consequences

24,366

Class II recallsTemporary or medically reversible health consequences

2,892

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,073 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/gias-foods-inc-recalls-bettergoods-authentic-italian-lemon-alfredo-fettuccine-because-possible-0Published October 1, 2026

Most affected stateHawaii 200 recalls mention this state

State: AS ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated October 1, 2026 ET

Summary (Year to date)

1,714 recalls have been announced year to date.
Sep 2026 was 3% higher than the previous complete period (Aug 2026: 182).
The highest complete period was Jun 2026 (297).
Oct 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,366
Class I	9,841
Class III	2,892
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,366
Class I	9,841
Class III	2,892
Not Yet Classified	2

FDA Recall Terminated Historical recordClass I

Trastuzumab Kit containing 1 vial Trastuzumab (nominal content: 440 mg); 1 20 mL multiple dose vial Bacteriostatic Water for Injection, USP (1.1% benzyl alcohol), Manufactured by Hospira, Inc., for Genentech, Inc., South San Francisco, CA 94080-4990, NDC 50242-903-69; and 1 Reconstitution Instructions per kit; Investigation Use only, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080-4990.

by Genentech Inc

Reason: Presence of Particulate Matter: One lot of Bacteriostatic Water for Injection, USP diluent vials that were packed with Trastuzumab Kits for investigational use has the potential to contain glass particulates.
Published: January 30, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

PredniSONE Tablets, USP, 20 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1477-01), b) 500-count tablets per bottle (NDC 0143-1477-05), and c) 1000-count tablets per bottle (NDC 0143-1477-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatowntown, NJ 07724.

by West-Ward Pharmaceutical Corp.

Reason: Presence of Foreign Substance: A complaint was received for black specks identified as stainless steel inclusions and cellulose with trace amounts of aluminum and iron-rich inclusions.
Published: January 30, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Lisinopril and Hydrochlorothiazide Tablets, 20 mg/25 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1264-01) and b) 1000-count tablets per bottle (NDC 0143-1264-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724.

by West-Ward Pharmaceutical Corp.

Reason: Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets.
Published: January 30, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Propylthiouracil Tablets, USP, 50 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1480-01) and b) 1000-count tablets per bottle (NDC 0143-1480-10), Rx only, Manufactured by: West-ward Pharmaceuticals Corp. Eatontown, NJ 07724.

by West-Ward Pharmaceutical Corp.

Reason: Presence of Foreign Substance: Uncharacteristic spots identified as steel corrosion, degraded tablet material and hydrocarbon oil with trace amounts of iron were found in tablets.
Published: January 30, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Lisinopril Tablets, USP 40 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1270-01); b) 1000-count tablets per bottle (NDC 0143-1270-10); Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724; and c) 1000-count tablets per bottle (NDC 24658-245-10); Rx only, Manufactured for: Blu Pharmaceuticals, Franklin, KY 42134; Manufactured By: West-ward Pharmaceutical Corp., Eatontown, N.J. 07724.

by West-Ward Pharmaceutical Corp.

Reason: Presence of Foreign Substance: Uncharacteristic black spots identified as a food grade lubricant with trace amounts of foreign particulates and stainless steel inclusions have been found in the tablets.
Published: January 30, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

I-C Drops, Eye Cleansing Agent, 15 ml ASN/Maxam P.O. Box 1277 Hood River, OR 97031

by James G. Cole, Inc.

Reason: Lack of Assurance of Sterility: The product is being recalled because the product label does not state sterile in accordance with 21 CFR Part 200.50(a)(1), Ophthalmic Preparations and Dispensers, and it is not in compliance with 21 CFR Part 349, Ophthalmic Drug Products for Over-The-Counter Use.
Published: January 23, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960 NDC 0093-5420-88

by Teva Pharmaceuticals USA, Inc.

Reason: Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life
Published: January 23, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Divalproex Sodium Delayed-Release Tablets, USP, 500 mg Valproic Acid Activity, 100-count tablets per bottle, Rx only, Manufactured by Upsher-Smith Laboratories, Inc., Minneapolis, MN 55447, NDC 0245-0182-11.

by Upsher Smith Laboratories, Inc.

Reason: Labeling: Label Error On Declared Strength; Some bottles of product were missing the color-coded strength on the primary display panel of the label.
Published: January 23, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Perindopril Erbumine Tablets, 8mg, 100 Tablets per Bottle, Rx Only, Boehringer Ingelheim, Roxane Laboratories Inc., Columbus, OH 43216, NDC 0054-0112-25.

by Boehringer Ingelheim Roxane Inc

Reason: Impurities/Degradation Products: Out of Specification results found for impurity B, identified as the drug's metabolite.
Published: January 23, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Prednisone tablets, USP, 10mg, Rx Only, Units of Use, NDC: a) 45802-303-67, 48-count Cartons, b) 45802-303-21, 21-count Cartons, Manufactured by: West-Ward Pharmaceutical Corporation, Eastown, NJ 07724, Distributed by: Perrigo, Allegan, MI 49040.

by L. Perrigo Co.

Reason: Presence of Foreign Substance(s); Perrigo has been notified of a recall by the manufacturer of this product, West-Ward Pharmaceuticals. This is a sub-recall due to tablets contaminated with trace amounts of food-grade lubricant, as well as stainless steel inclusions
Published: January 23, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Triamcinolone 10 mg/mL P, 40mg/mL P, 40mg/mL PF and 80 mg/mL PF in 1 mL, 2 mL, 5 mL, and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason: Lack of Assurance of Sterility
Published: January 9, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Saline 10% and 3%, in 5 mL and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason: Lack of Assurance of Sterility
Published: January 9, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Omnipaque 240mg/mL PF, 300mg/mL PF, in 3 mL, 5 mL, and 10 mL, vials, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason: Lack of Assurance of Sterility
Published: January 9, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Lidocaine 1% PF, 2% PF, and 4% PF, in 1 mL, 2 mL, 5 mL, and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason: Lack of Assurance of Sterility
Published: January 9, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Lidocaine/Dextrose 5%/7.5% PF, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason: Lack of Assurance of Sterility
Published: January 9, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Isovue 200 mg/mL PF and 300 mg/mL PF, Vials, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason: Lack of Assurance of Sterility
Published: January 9, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Hyaluronidase 150 u/ml PF, 1 mL, 5 mL, and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason: Lack of Assurance of Sterility
Published: January 9, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Glycerin 100% PF, 1mL, 2 mL, and 5 mL vials, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason: Lack of Assurance of Sterility
Published: January 9, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dexamethasone Sodium Phosphate 4 mg/mL vials PF, 6 mg/mL PF vials, and 8 mg/mL PF vials, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason: Lack of Assurance of Sterility
Published: January 9, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Clonidine 100 mcg/mL PF, 1mL and 2 mL vials, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason: Lack of Assurance of Sterility
Published: January 9, 2013
Distribution: Nationwide

View recall →

Data last updated: October 1, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.